These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10971057)

  • 1. Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate.
    Katsantonis J; Adler Y; Orfanos CE; Zouboulis CC
    Dermatology; 2000; 201(1):37-9. PubMed ID: 10971057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
    Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
    Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.
    Liu S; Ren J; Xia Q; Wu X; Han G; Ren H; Yan D; Wang G; Gu G; Li J
    Am J Med Sci; 2013 Dec; 346(6):467-72. PubMed ID: 23689052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease.
    Adam B; Calikoglu E
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):318-20. PubMed ID: 15096143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet's disease in the Shanghai Adamantiades-Behçet's disease database: a prospective cohort study.
    Zhang L; Tian Y; Ye JF; Lin CH; Guan JL
    Orphanet J Rare Dis; 2019 Nov; 14(1):274. PubMed ID: 31779646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells.
    Zouboulis CC; Katsantonis J; Ketteler R; Treudler R; Kaklamani E; Hornemann S; Kaklamanis P; Orfanos CE
    Arch Dermatol Res; 2000 Jun; 292(6):279-84. PubMed ID: 10929768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of serum interleukin-20 levels in patients with Behçet's disease.
    Enecik ME; Mavi B; Yücel Ç; Keskin G; Yıldız M
    Adv Clin Exp Med; 2018 Oct; 27(10):1391-1395. PubMed ID: 30048054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behçet's disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity.
    Müftüoğlu AU; Yazici H; Yurdakul S; Tüzün Y; Pazarli H; Güngen G; Deniz S
    Int J Dermatol; 1986 May; 25(4):235-9. PubMed ID: 3710672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of vascular endothelial growth factor and CD34 in oral aphthous lesions of Behçet's disease.
    Yalçin B; Arda N; Tezel GG; Erman M; Alli N
    Anal Quant Cytol Histol; 2006 Dec; 28(6):303-6. PubMed ID: 17220143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease.
    Düzgün N; Ayaşlioğlu E; Tutkak H; Aydintuğ OT
    Rheumatol Int; 2005 Jan; 25(1):1-5. PubMed ID: 14600787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behçet's disease.
    Wang LM; Kitteringham N; Mineshita S; Wang JZ; Nomura Y; Koike Y; Miyashita E
    Arch Dermatol Res; 1997 Jul; 289(8):444-7. PubMed ID: 9266021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.
    Kim DJ; Baek SY; Park MK; Park KS; Lee JH; Park SH; Kim HY; Kwok SK
    J Korean Med Sci; 2013 Aug; 28(8):1145-53. PubMed ID: 23960440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation markers in Behçet's disease.
    Coskun B; Saral Y; Gödekmerdan A; Erden I; Coskun N
    Skinmed; 2005; 4(5):282-6. PubMed ID: 16282749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease.
    Şahin E; Karaman G; Uslu M; Karul A; Şendur N; Şavk E
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1498-502. PubMed ID: 22035239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Colchicine on Mean Platelet Volume in Behcet's Disease.
    Ataş H; Cemil BC; Canpolat F; Gönül M
    Ann Clin Lab Sci; 2015; 45(5):545-9. PubMed ID: 26586706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.